63 results

Shire investors will receive $30.33 in cash and either 0.839 new Takeda shares or 1.678 Takeda ADSs for each share. Photograph: Clodagh Kilcoyne/Reuters

Takeda Pharma agreed to buy Ireland-headquartered Shire for £45.3 billion (€51.6 billion) on Tuesday after the Japanese company raised the amount of (...)

Shares in Takeda tumbled further on Wednesday on news of the Shire deal. Photograph: Suzanne Plunkett/Reuters

Rare disease drug maker Shire said on Tuesday it was willing to recommend a sweetened $64 billion offer from Japan’s Takeda to shareholders, in what (...)

Traders work on the floor of the New York Stock Exchange  . Photographer: Michael Nagle/Bloomberg

European shares steadied on Tuesday as a batch of company updates failed to set a clear trend and chipmakers were weighed down by a warning of a down(...)

Shire’s board “is considering its position” on a new bid from Takeda.

Dublin-based pharma giant Shire is considering a new offer from Takeda Pharmaceutical after the Japanese drugmaker revised its roughly $60 billion (€4(...)

Shares in CRH, the largest company on the Iseq, jumped by 3.4 per cent to €3.40 on Friday. Photograph: Cyril Byrne

Shares in CRH soared the most in eight months on Friday, lifting Dublin’s Iseq index, as investors mulled over comments made by the building materials(...)

Two sources with direct knowledge of the matter said last week that Takeda had sounded out its major creditors for loans to fund a potential Shire bid.  Photograph:  Suzanne Plunkett/Reuters

Shire, the Irish rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to (...)

Shares in Norwegian Air rose 47%  after IAG said it was considering marking an offer for the carrier. Photograph: Reuters

Ireland’s benchmark Iseq overall index outperformed wider European markets on Thursday, rising 0.95 per cent. European shares rose alongside a relie(...)

Takeda is not considering purchasing only some businesses or assets, Credit Suisse said in a note. Photograph: Kim Kyung-Hoon/Reuters

Takeda Pharmaceutical chief executive Christophe Weber is contemplating a deal for all of Shire, telling a select audience that size is not an obstacl(...)

Is Takeda’s pursuit of Irish rare disease drug group Shire over even before it has properly begun? Photograph: Suzanne Plunkett/Reuters

Is Takeda’s pursuit of Irish rare disease drug group Shire over even before it has properly begun? Japan’s largest drugmaker was flushed out into the(...)

Amazon fell more than 5 per cent after reports that president Donald Trump was looking to target the company by changing its tax treatment.

Shares rose generally yesterday with most European indices bar Germany’s Dax up. Bank of Ireland and AIB rose on news that the Minister for Finance, P(...)

  • « First
  • Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »